Spectranetics GlideLight Laser Sheath

 

May 2, 2012

As part of the company’s vision to safely manage every lead, Spectranetics Corp.'s GlideLight delivers more precise control to reduce the force for safe lead extraction.

Spectranetics’ current laser sheath, the SLS II, requires significantly less force to advance than mechanical telescoping sheaths. GlideLight is a major leap forward, requiring 55 percent less force to advance than SLS II.

A limited market release of GlideLight will be conducted to gain early experience prior to a broader controlled launch. It received U.S. Food and Drug Administration (FDA) approval in May 2012 for removal of cardiac leads.

For more information: www.spectranetics.com